Immunic | VTL - Ordinary Share Capital


Immunic reported $8K in Ordinary Share Capital for its fiscal quarter ending in June of 2024.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Cipla INR 807.77M 807.43M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1.02M Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Enanta Pharmaceuticals USD 212K 1000 Dec/2023
Grifols EUR 680.58M 846.11K Dec/2025
Immunic USD 8K 4K Jun/2024
Insmed USD 214.26M 1.67M Dec/2025
Omeros USD 611K 17K Dec/2023
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quidel USD 67.9M 200K Sep/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
United Therapeutics USD 43.64M 740K Dec/2025
Xoma USD 87K 1000 Jun/2024